Web18 May 2024 · Winstone TA, Assayag D, Wilcox PG, et al. Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review. … Web19 Sep 2006 · A multitude of factors in a lung with scleroderma, including cytokines and disturbance of cellular immunity, may predispose an individual to peripheral tumours as …
Predictors of progression in systemic sclerosis patients with ...
Web12 Aug 2024 · Conditions such as scleroderma, rheumatoid arthritis, and dermatopolymyositis disproportionately affect the lungs, whereas systemic lupus … Web1 May 2024 · To address this issue, the present study examined whether radiographic progression of ILD in patients with SSc receiving treatment predicts long-term mortality. … the semi transverse axis of the hyperbola
Description of a single centre cohort of patients with systemic ...
In a retrospective histopathological evaluation of 80 patients with SSc and biopsy proven ILD, 76 percent had nonspecific interstitial pneumonia (NSIP) and 11 percent had usual interstitial pneumonia (UIP) [ 8 ]. The five-year survival rate for patients with NSIP and UIP was similar, 82 and 91 percent, respectively. See more INTRODUCTION Interstitial lung disease (ILD) is a frequent complication of systemic sclerosis (SSc) that is often progressive and has a poor prognosis [1-7]. SSc-associated ILD consists of various histopathologic … See more INITIATING THERAPY The optimal treatment for systemic sclerosis-associated interstitial lung disease (SSc-ILD) is not known. … See more TYPES OF INTERSTITIAL LUNG DISEASE The term interstitial lung disease (ILD) is broadly used to describe a heterogeneous group … See more A minority of patients with SSc-ILD have the histopathologic pattern of UIP [8], the characteristic pattern associated with idiopathic pulmonary fibrosis (IPF). This pattern is characterized by the presence of scattered foci of … See more WebSAN DIEGO – Patients with scleroderma-associated isolated pulmonary arterial hypertension have a slightly higher mortality risk than patients with scleroderma … WebSystemic sclerosis has a high mortality—greater than any other rheumatic disease—despite evidence of improved survival, especially for patients with diffuse cutaneous systemic sclerosis. , For the patient, systemic sclerosis is associated with great uncertainty of outcome and development of manifestations that are potentially lethal or can reduce … these money is mine